Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS [Phase 4]
Clinical trial update on Hemocontrol assessing its effectiveness in reducing long-term cardiovascular events in patients with chronic kidney…
-
FDA approval · 2012-06-28FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved the supplemental application for Zemplar (paricalcitol) from AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: The Boston Scientific ACCESS Trial [Phase 2, Phase 3]
A Phase 2/3 trial called ACCESS by Maquet Cardiovascular investigating renal disease and kidney failure has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents [Phase 4]
Phase 4 trial evaluating the Norditropin NordiFlex device versus the device previously used by patients or their parents; the study is compl…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated using donor stem cells with alemtuzumab to prevent organ rejection in kidney transplant recipients; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D [Phase 4]
Phase 4 trial comparing paricalcitol to cinacalcet with low-dose vitamin D in patients with chronic kidney disease and secondary hyperparath…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology [Phase 1, Phase 2]
Clinical trial update for phase 1/2 studies evaluating the renal effects of an unspecified angiotensin converting enzyme inhibitor in adults…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction [Phase 3]
A Phase 3 clinical trial compares lanthanum carbonate, calcium acetate, and dietary phosphorus restriction for managing mineral balance in c…
-
CLINICAL_TRIALS research · 2012-06-08Clinical Trial Update: Study of Subclinical Viral Infection
An update on a clinical trial studying subclinical viral infection sponsored by Seattle Children's Hospital, involving kidney transplantatio…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy [Phase 2]
Phase 2 trial of FK778 in renal transplant recipients with untreated BK polyomavirus nephropathy has been terminated.
-
FDA label_change · 2012-06-05FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for Feraheme (ferumoxytol) to update the product labeling following AMAG Pharmaceuticals' submission…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) [Phase 2]
A Phase 2 trial evaluating pirfenidone for focal segmental glomerulosclerosis (kidney fibrosis) has completed and posted results in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Phase 2]
Phase 2 study evaluating HS219 in chronic kidney disease patients on hemodialysis with hyperphosphatemia; the trial completed and results we…
-
FDA approval · 2012-06-01FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX, LLC.)
FDA approved the original application for calcium acetate (Calcium Acetate) by Chartwell RX, LLC as a generic drug.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA [Phase 2]
Phase 2 trial evaluating the safety and efficacy of peginesatide for treating anemia in dialysis patients not receiving an ESA. Results were…
-
CLINICAL_TRIALS research · 2012-05-30Clinical Trial Update: Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients [NA]
This clinical trial update covers a study on adherence to a phosphorus-restricted diet and phosphate binder therapy in patients with chronic…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis [Phase 2]
A Phase 2 study evaluating peginesatide for maintenance treatment of anemia in participants on hemodialysis has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU) [Phase 2]
Extension study evaluating long-term safety and tolerability of peginesatide for anemia in chronic kidney disease; the trial was terminated …
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD [Phase 2]
This clinical trial update reports the termination of a Phase 2 extension study evaluating the safety and tolerability of peginesatide for l…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D [Phase 4]
Phase 4 trial update evaluating whether vitamin D derivatives reduce proteinuria in patients with chronic kidney disease and concurrent vita…
-
FDA approval · 2012-05-11FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., authorizing a generic version of the diuretic. Thi…
-
CLINICAL_TRIALS research · 2012-04-12Clinical Trial Update: Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy
This completed observational study assesses the prevalence of Fabry disease in chronic kidney disease patients not on renal replacement ther…
-
CLINICAL_TRIALS research · 2012-04-12Clinical Trial Update: Managing Chronic Kidney Disease in Eastern North Carolina [NA]
This document notes a completed clinical trial sponsored by East Carolina University investigating the management of Chronic Kidney Disease …
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Quality Assessment Creatinines in Plasma and Urine
This clinical trial update assesses the quality of creatinine measurements in plasma and urine for chronic kidney disease. The study has com…
-
CLINICAL_TRIALS research · 2012-04-10Clinical Trial Update: Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients [Phase 4]
Phase 4 clinical trial investigating the anti-proteinuric effect of calcitriol in patients with non-diabetic kidney disease.